Santa Barbara, CA (PRWEB) November 8, 2010
Santa Barbara Medical Innovations, SBMI, announces today that over 20,000 patients have undergone Erchonia’s Zerona® painless, body-contouring laser treatment to date, an increase of 48% since May 2010, with physicians reporting their patients have lost an average of 4.1 inches. Collectively, these 20,000 patients have lost an estimated 82,000 inches, or 1.3 miles of fat, thanks to the non-invasive, low level laser technology.
The U.S. Food and Drug Administration recently granted the Zerona laser 510(k) clearance, finding the Zerona laser to be safe and effective for non-invasive body-contouring of the waist, hips and thighs. FDA clearance followed after the completion of a placebo-controlled, randomized, double-blind, multi-site clinical investigation evaluating sixty-seven study participants. Participants lost an average of 3.65 inches across patient’s waist, hips, and thighs in as little as two weeks.
The Zerona emits a low-level, or cold, output energy that generates no thermal effect on the body’s tissue eliminating any risk to the patient. Zerona has been clinically proven to target fat cells causing their immediate collapse thereby significantly reducing body volume. Through a natural process of fat removal, the laser-released fat is safely removed and broken down. Zerona is a truly non-invasive, painless procedure without side effects or downtime.
“The 20,000 patient mark is a great milestone for Zerona,” says Chip Conk, founder and CEO of SBMI. “Zerona’s FDA clearance has given both doctors and patients confidence that the technology is a safe and effective non-invasive alternative to reduce fat.”
Presently, over 700 Zerona lasers are in use throughout North America and the numbers are steadily growing in part due to SBMI’s “ZERO” investment business model, which puts the Zerona laser in the hands of physicians with no capital equipment investment and only a small start-up fee. With the recent FDA market clearance, SBMI has experienced record months, with physicians eager to offer their patients an FDA-approved device, cleared as both safe and effective for circumferential loss of the waist, hips and thighs.
SBMI is dedicated to bringing clinically proven, innovative health and wellness products that are safe and effective to market. SBMI is the exclusive North American distributor of Zerona® the FDA-approved, non-invasive, body-contouring device, as well as the Erchonia EML, the only laser device FDA approved for pain during liposuction and breast surgery. For more information, visit http://www.sbmi.com.
Erchonia is the global leader in low level laser healthcare applications. Over the last 15 years Erchonia has been conducting research & development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven to be safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For more information, visit http://www.erchonia.com.
# # #